Wang Li , Yali Fan , Wenjie Zhu, Zheng Liang, Shuping Nie
{"title":"CsrR modulates biofilm formation of ST-17 GBS through the regulation of a novel adhesion factor, BapB","authors":"Wang Li , Yali Fan , Wenjie Zhu, Zheng Liang, Shuping Nie","doi":"10.1016/j.micpath.2025.107873","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>The hypervirulent ST-17 clone of Group B <em>Streptococcus</em> (GBS) is a leading cause of neonatal invasive meningitis. The link between GBS biofilm formation and the ST-17 lineage is established, and the inhibition of GBS biofilm formation by CsrR involves the regulation of adhesins. However, the specific adhesins involved in biofilm formation in ST-17 GBS strains are unknown.</div></div><div><h3>Hypothesis/gap statement</h3><div>CsrR inhibits biofilm formation of ST-17 GBS through the regulation of specific adhesins.</div></div><div><h3>Aims</h3><div>To identify the adhesins contributing to biofilm formation in the ST-17 lineage.</div></div><div><h3>Methodology</h3><div>Comparative proteomics analyses of a strong biofilm-forming ST-17 strain and its <em>csrR</em> deletion mutant (<em>ΔcsrR</em>) were performed to identify the specific proteins involved in biofilm formation in ST-17 GBS. qPCR and biofilm formation assays were used to validate the proteomics analysis.</div></div><div><h3>Results</h3><div>A novel biofilm-associated protein, BapB, absent in non-biofilm-forming ST-17 GBS strains (e.g., COH1), was identified. Biofilm production was significantly attenuated in the <em>bapB</em> deletion mutant (<em>ΔbapB</em>), reducing GBS adherence to fibronectin and laminin.</div></div><div><h3>Conclusion</h3><div>BapB plays a crucial role in biofilm formation. It may be a potential target for design of new therapeutic approaches against GBS.</div></div>","PeriodicalId":18599,"journal":{"name":"Microbial pathogenesis","volume":"207 ","pages":"Article 107873"},"PeriodicalIF":3.5000,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbial pathogenesis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0882401025005984","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
The hypervirulent ST-17 clone of Group B Streptococcus (GBS) is a leading cause of neonatal invasive meningitis. The link between GBS biofilm formation and the ST-17 lineage is established, and the inhibition of GBS biofilm formation by CsrR involves the regulation of adhesins. However, the specific adhesins involved in biofilm formation in ST-17 GBS strains are unknown.
Hypothesis/gap statement
CsrR inhibits biofilm formation of ST-17 GBS through the regulation of specific adhesins.
Aims
To identify the adhesins contributing to biofilm formation in the ST-17 lineage.
Methodology
Comparative proteomics analyses of a strong biofilm-forming ST-17 strain and its csrR deletion mutant (ΔcsrR) were performed to identify the specific proteins involved in biofilm formation in ST-17 GBS. qPCR and biofilm formation assays were used to validate the proteomics analysis.
Results
A novel biofilm-associated protein, BapB, absent in non-biofilm-forming ST-17 GBS strains (e.g., COH1), was identified. Biofilm production was significantly attenuated in the bapB deletion mutant (ΔbapB), reducing GBS adherence to fibronectin and laminin.
Conclusion
BapB plays a crucial role in biofilm formation. It may be a potential target for design of new therapeutic approaches against GBS.
期刊介绍:
Microbial Pathogenesis publishes original contributions and reviews about the molecular and cellular mechanisms of infectious diseases. It covers microbiology, host-pathogen interaction and immunology related to infectious agents, including bacteria, fungi, viruses and protozoa. It also accepts papers in the field of clinical microbiology, with the exception of case reports.
Research Areas Include:
-Pathogenesis
-Virulence factors
-Host susceptibility or resistance
-Immune mechanisms
-Identification, cloning and sequencing of relevant genes
-Genetic studies
-Viruses, prokaryotic organisms and protozoa
-Microbiota
-Systems biology related to infectious diseases
-Targets for vaccine design (pre-clinical studies)